Expert Interview: Pfizer/BioNTech Immune Response in Pediatric Clinical Trials

Expert Interview

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children.

Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.

This article originally appaered on Contemporary Pediatrics.

Related Videos
Related Content
COVID-19 Pandemic Exacerbated Functional Limitations Among Older Adults With Diabetes

COVID-19 Pandemic Exacerbated Functional Limitations Among Older Adults With Diabetes

April 17th 2024
Article

Overall, older adults with diabetes faced a 53% higher risk of developing at least 1 functional limitation during the pandemic compared to older adults without diabetes.

pharmacist holds prescription packet

Good Neighbor Pharmacy Customers Across the US Reflect and Look Forward

September 20th 2021
Podcast

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

Federal Retail Pharmacy Program Partners Critical in Ensuring Vaccine Access

Federal Retail Pharmacy Program Partners Critical in Ensuring Vaccine Access

April 4th 2024
Article

Understanding the role of pharmacies in vaccination rates can help prepare officials for the next public health emergency.

Over the Counter

McKesson Series: Using Technology to Simplify Vaccination Programs

December 22nd 2020
Podcast

Our latest podcast episode discusses how pharmacies can tap technology to boost vaccination programs for COVID-19 vaccines and others.

Assessing How COVID-19 Impacted Pharmacists’ Work Activities, Job Satisfaction

Assessing How COVID-19 Impacted Pharmacists’ Work Activities, Job Satisfaction

March 27th 2024
Article

Two posters presented at APhA 2024 examined how the COVID-19 pandemic impacted pharmacists and their work.

Slideshow: Assessing the COVID-19 Pandemic After its 2020 Peak

Slideshow: Assessing the COVID-19 Pandemic After its 2020 Peak

March 22nd 2024
Article

Four posters presented at the American Pharmacists Association Annual Meeting and Exposition explored how individuals and health care providers have been handling the COVID-19 pandemic.

© 2024 MJH Life Sciences

All rights reserved.